Overview

Optimal Duration of Olanzapine Add-on Therapy in Major Depression

Status:
Withdrawn
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
Evaluation of olanzapine versus placebo in the continuation therapy of subjects with major depression who had a response with additional olanzapine to an antidepressant.
Phase:
Phase 3
Details
Lead Sponsor:
Charite University, Berlin, Germany
Collaborator:
Eli Lilly and Company
Treatments:
Olanzapine